Literature DB >> 18496581

[Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006].

M García Cenoz1, J Castilla, Y Montes, J Morán, A Salaberri, F Elía, Y Floristán, I Rodrígo, F Irisarri, M Arriazu, A Zabala, A Barricarte.   

Abstract

Varicella is an acute and highly contagious disease produced by the varicella-zoster virus, which leaves lasting immunity. Herpes zoster is produced by reactivation of a latent infection of the same virus. The introduction of systematic and free vaccination against varicella in children of 15 months in Navarre from 2007 onwards can be expected to produce important epidemiological changes. For this reason we describe the previous epidemiological situation in the period from 2005 to 2006. We analysed all cases of varicella and herpes zoster registered in the electronic clinical files of primary care, in the database of hospital discharges and in the mortality register. Between 2005 and 2006, 9,908 cases of varicella were diagnosed (8.29 annually per 1,000 inhabitants), with 90% in children under 15 years old. There were 80 hospital admissions (8 for every 1,000 cases), complications in 2.5 out of every 1,000 cases, and there was one death due to this cause (0.1 per 1,000 cases). In the same period, 4,959 cases of herpes zoster were diagnosed (4.15 cases per 1,000 inhabitants), half in people over 55 years old. There were 179 hospital admissions (36 per 1,000 cases), whose average age was 77, and 83 presented complications (16.7 per 1,000 cases). This epidemiological pattern is similar to that found in other places before the introduction of the vaccine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18496581     DOI: 10.4321/s1137-66272008000100006

Source DB:  PubMed          Journal:  An Sist Sanit Navar        ISSN: 1137-6627            Impact factor:   0.829


  12 in total

1.  The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.

Authors:  Giorgio Guzzetta; Piero Poletti; Stefano Merler; Piero Manfredi
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

2.  Herpes zoster and postherpetic neuralgia in Catalonia (Spain).

Authors:  Luis Salleras; Montse Salleras; Patricia Salvador; Núria Soldevila; Andreu Prat; Patricio Garrido; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).

Authors:  María D Esteban-Vasallo; M Felicitas Domínguez-Berjón; Ruth Gil-Prieto; Jenaro Astray-Mochales; Angel Gil de Miguel
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

Review 4.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

5.  Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain).

Authors:  Ana M Cebrián-Cuenca; Javier Díez-Domingo; María San-Martín Rodríguez; Joan Puig-Barberá; Jorge Navarro-Pérez
Journal:  BMC Fam Pract       Date:  2010-05-06       Impact factor: 2.497

6.  A systematic literature review of herpes zoster incidence worldwide.

Authors:  Désirée van Oorschot; Hilde Vroling; Eveline Bunge; John Diaz-Decaro; Desmond Curran; Barbara Yawn
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

7.  Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.

Authors:  Ana M Cebrián-Cuenca; Javier Díez-Domingo; María San-Martín-Rodríguez; Joan Puig-Barberá; Jorge Navarro-Pérez
Journal:  BMC Infect Dis       Date:  2011-11-01       Impact factor: 3.090

8.  The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study.

Authors:  Valentina Marziano; Piero Poletti; Giorgio Guzzetta; Marco Ajelli; Piero Manfredi; Stefano Merler
Journal:  Proc Biol Sci       Date:  2015-04-07       Impact factor: 5.349

Review 9.  Similar herpes zoster incidence across Europe: results from a systematic literature review.

Authors:  Sybil Pinchinat; Ana M Cebrián-Cuenca; Hélène Bricout; Robert W Johnson
Journal:  BMC Infect Dis       Date:  2013-04-10       Impact factor: 3.090

10.  Herpes zoster surveillance using electronic databases in the Valencian Community (Spain).

Authors:  Nuria Morant-Talamante; Javier Diez-Domingo; Sergio Martínez-Úbeda; Joan Puig-Barberá; Sara Alemán-Sánchez; Lina Pérez-Breva
Journal:  BMC Infect Dis       Date:  2013-10-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.